{"organizations": [], "uuid": "0978cc898faa8dfe62375436bb3ba67f6099cbc7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180108.html", "section_title": "Archive News &amp; Video for Monday, 08 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-bioceres-sa-files-for-us-ipo-of-up/brief-bioceres-s-a-files-for-u-s-ipo-of-up-to-100-million-idUSEMN1CEPTS", "country": "US", "domain_rank": 408, "title": "BRIEF-Bioceres S.A. Files For U.S. IPO Of Up To $100 Million", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.003, "site_type": "news", "published": "2018-01-08T21:12:00.000+02:00", "replies_count": 0, "uuid": "0978cc898faa8dfe62375436bb3ba67f6099cbc7"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-bioceres-sa-files-for-us-ipo-of-up/brief-bioceres-s-a-files-for-u-s-ipo-of-up-to-100-million-idUSEMN1CEPTS", "ord_in_thread": 0, "title": "BRIEF-Bioceres S.A. Files For U.S. IPO Of Up To $100 Million", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "jefferies", "sentiment": "none"}], "organizations": [{"name": "sec", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "brief-bioceres s.a.", "sentiment": "negative"}, {"name": "nyse", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 8 (Reuters) -\n* BIOCERES S.A. FILES FOR U.S. IPO OF UP TO $100 MILLION – SEC FILING\n* BIOCERES S.A. SAYS IT INTENDS TO APPLY TO HAVE ITS ADS LISTED ON NYSE UNDER THE SYMBOL “BIOX”\n* BIOCERES S.A. SAYS JEFFERIES, PIPER JAFFRAY, SANTANDER AND MIRABAUD SECURITIES ARE AMONG UNDERWRITERS TO IPO\n* BIOCERES S.A. SAYS PROPOSED IPO PRICE IS AN ESTIMATE SOLELY FOR CALCULATING SEC REGISTRATION FEE Source text: bit.ly/2Ejwkqk\n ", "external_links": ["http://bit.ly/2Ejwkqk", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-08T21:12:00.000+02:00", "crawled": "2018-01-09T17:13:38.001+02:00", "highlightTitle": ""}